| P2093 | author name string | Fernando Huete-Toral | |
| | Almudena Crooke | |
| | Jesus Pintor | |
| | Alejandro Martínez-Águila | |
| | Basilio Colligris | |
| P2860 | cites work | International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors | Q24623433 |
| | Influence of dietary melatonin on photoreceptor survival in the rat retina: an ocular toxicity study | Q24656986 |
| | Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight | Q24679626 |
| | Phototransduction by retinal ganglion cells that set the circadian clock | Q28217956 |
| | Ocular axial length and choroidal thickness in newly hatched chicks and one-year-old chickens fluctuate in a diurnal pattern that is influenced by visual experience and intraocular pressure changes | Q32071956 |
| | Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes | Q33206561 |
| | Use of melatonin to prevent selenite-induced cataract formation in rat eyes | Q33260815 |
| | Protective effects of melatonin and aminoguanidine on the cornea in streptozotocin-induced diabetic rats | Q33354370 |
| | Oxidative damage and protection of the RPE. | Q33837754 |
| | Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor | Q33964991 |
| | Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study | Q34319912 |
| | The immune response in glaucoma: a perspective on the roles of oxidative stress | Q34388254 |
| | Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy | Q35015863 |
| | Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma | Q35704069 |
| | Genetic aspects of melatonin biology | Q35882505 |
| | Basis of chloride transport in ciliary epithelium | Q35896172 |
| | The role of calcium-independent phospholipase A2γ in modulation of aqueous humor drainage and Ca2+ sensitization of trabecular meshwork contraction | Q35900703 |
| | Agomelatine, a melatonin receptor agonist with 5-HT(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicity | Q46604799 |
| | Melatonin inhibitory effect on cAMP accumulation in the chick retina development | Q46700301 |
| | Melatonin pharmacokinetics in premenopausal and postmenopausal healthy female volunteers | Q46856808 |
| | Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin | Q46865150 |
| | Melatonin receptors in chick ocular tissues: implications for a role of melatonin in ocular growth regulation | Q46872518 |
| | Effects of melatonin in age-related macular degeneration | Q46884759 |
| | Effects of intraperitoneal vitamin E, melatonin and aprotinin on leptin expression in the guinea pig eye during experimental uveitis | Q46918197 |
| | Pineal indoleamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates | Q48106892 |
| | Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin | Q48734156 |
| | Retinal Localization of the Hydroxyindole-O-methyl Transferase (HIOMT) in the Rat | Q48811214 |
| | Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic wistar rats. | Q48913574 |
| | Effect of experimental glaucoma on the non-image forming visual system. | Q50279367 |
| | Influence of different artificial lighting regimes on intraocular pressure circadian profile in the dog (Canis familiaris). | Q51564886 |
| | Aqueous humor dynamics during the day and night in healthy mature volunteers. | Q51592670 |
| | Aqueous humor dynamics during the day and night in juvenile and adult rabbits. | Q51726050 |
| | Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. | Q52579934 |
| | Confirmation of the rat model of chronic, moderately elevated intraocular pressure. | Q53746354 |
| | Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. | Q53926835 |
| | Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. | Q54024633 |
| | Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT. | Q54337814 |
| | Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity | Q54646753 |
| | Protective effects of melatonin in experimental free radical-related ocular diseases. | Q36379509 |
| | Melatonin: Nature's most versatile biological signal? | Q36525997 |
| | Melatonin in the eye: implications for glaucoma | Q36686363 |
| | Melatonin receptors in the eye: location, second messengers and role in ocular physiology | Q36710431 |
| | Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults | Q36928856 |
| | Hypoxia-ischemia and retinal ganglion cell damage | Q37236104 |
| | Pharmacological management of primary open-angle glaucoma: second-line options and beyond | Q37253030 |
| | Diabetic retinopathy and angiogenesis | Q37387307 |
| | Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?--an exemplary analysis on the basis of two beta-blockers | Q37592669 |
| | Melatonin reprogrammes proteomic profile in light-exposed retina in vivo | Q37625190 |
| | Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists. | Q37763715 |
| | Neuroprotection in glaucoma – Is there a future role? | Q37783712 |
| | The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential | Q37809108 |
| | Emerging drugs for ocular hypertension | Q37847182 |
| | The molecular basis of retinal ganglion cell death in glaucoma | Q37966513 |
| | Novel therapies for glaucoma: a patent review 2007 - 2011. | Q37970701 |
| | Melatonin synthetic analogs as nitric oxide synthase inhibitors | Q38003431 |
| | An unexpected effect of 5-MCA-NAT in chick retinal development. | Q38434597 |
| | Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligand. | Q39731055 |
| | Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress | Q40562642 |
| | Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications | Q41377025 |
| | Studies on the role of the retinal dopamine/melatonin system in experimental refractive errors in chickens | Q41675878 |
| | Therapeutic effect of melatonin in experimental uveitis. | Q41895570 |
| | 5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit | Q41937917 |
| | Identification of the melatonin-binding site MT3 as the quinone reductase 2. | Q42630663 |
| | Effect of chondroitin sulfate on intraocular pressure in rats | Q43007259 |
| | Melatonin: a novel neuroprotectant for the treatment of glaucoma | Q43107101 |
| | Pharmacokinetics of orally administered melatonin in critically ill patients | Q43195642 |
| | Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits | Q43566827 |
| | Melatonin delays photoreceptor degeneration in the rds/rds mouse | Q43575894 |
| | The effect of melatonin on eye lens of rats exposed to ultraviolet radiation | Q43615041 |
| | Sun exposure and age-related macular degeneration. An Australian case-control study | Q43909889 |
| | Effects of pinealectomy and melatonin on the retrograde degeneration of retinal ganglion cells in a novel model of intraorbital optic nerve transection in mice | Q44032675 |
| | The effects of constant and diurnal illumination of the pineal gland and the eyes on ocular growth in chicks | Q44526933 |
| | Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin | Q44532250 |
| | Antioxidant protection in cultured corneal cells and whole corneas submitted to UV-B exposure | Q44713465 |
| | Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities | Q44763557 |
| | Retinal oxidative stress induced by high intraocular pressure | Q45071741 |
| | Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits | Q45082610 |
| | Cellular and vascular changes in the retina of neonatal rats after an acute exposure to hypoxia. | Q45993787 |
| | Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia | Q46082009 |
| | Melatonin reduces oxidative stress in the rat lens due to radiation-induced oxidative injury | Q46268380 |
| | Effects of 530 nm green light on refractive status, melatonin, MT1 receptor, and melanopsin in the guinea pig. | Q46415458 |
| | Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. | Q46433031 |
| | A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid | Q46566379 |
| | Radioprotective effects of melatonin on radiation-induced cataract | Q46575504 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 989-1001 | |
| P577 | publication date | 2012-08-04 | |
| P1433 | published in | Expert Opinion on Drug Discovery | Q5421204 |
| P1476 | title | Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential | |
| P478 | volume | 7 | |